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BACKGROUND OF THE INVENTION
The glucuronic acid derivatives of retinol and reti noic acid were ?rst obtained as biliary metabolites of vitamin A (Dunagin et al. Science, 148: 86-87, 1965; Zachman et al. J. Lipid Res. 7: 3-9, 1966; Lippel and Olson, J. Lipid Res. 9: 580-586, 1968) . The physiolog ical signi?cance of these glucuronides are not known yet, but recent ?ndings of the presence of retinoyl glu curonide in the small intestine (Zile et al. J. Biol. Chem. 257: 3544-3550, 1982) and in the liver (McCormick et al. Biochemistry, 22: 3933-3940, 1984) suggest that the glucuronides of vitamin A might play some important role in the overall metabolism of vitamin A. Using very small quantities of natural retinoyl glucuronide, it was shown that the compound is biologically more active than retinoic acid in the vaginal smear assay (Sietsema and DeLuca, J. Nutr. 112: 1481 Nutr. 112: -1489 Nutr. 112: , 1982 , and 30-100% as active as retinoic acid in the rat growth assay (Nath and Olson, J. Nutr. 93: 461-469, 1965 Retinoids, vol. 1, p. 281-392, ed. Sporn et al. Academic Press, Orlando, Fla., 1984) . With the avail ability of a water-soluble derivative of vitamin A, the problem of absorption and transport of vitamin A is overcome.
Several retinoids, retinoic acid in particular, have been found very effective in the topical treatment and cure of xerophthalmia and corneal epithelial wounds (Ubels et al. Current Eye Res. 4: 1049 -1057 , 1985 . These retinoids being water-insoluble pose signi?cant problems in the formulation of a suitable vehicle for the clinical use. With the availability of water-soluble glu curonide derivatives, the formulation problem is over come, since these derivatives could be applied as aque ous eye drops.
The ?rst chemical synthesis of retinoyl B-glucuro nide was reported by us (Barua & Olson, J. Lipid Res. 26: 1277 -1282 , 1985 , and involves a two-step proce dure. Retinoyl ?uoride was allowed ?rst to react with 6,3-glucuronolactone to produce the 6,3-lactone of re tinoyl glucuronic acid, which was then hydrolysed with very dilute alkali to give retinoyl B-glucuronide. The present invention is an improvement over the two-step procedure. The presence of the glucuronic acid moiety renders the compounds water-soluble.
The starting material for the synthesis of retinoyl B-glucuronide is retinoyl ?uoride. Our U.S. Pat. No. 4,473,503 describes the preparation of retinoyl ?uoride and is incorporated herein by references. Retinoyl fluo ride, unlike most acyl chlorides, is stable in aqueous solution for several days and is hydrolyzed to retinoic acid only on heating in the presence of alkali or acid. It is not appreciably hydrolyzed to retinoic acid even in the presence of bicarbonate at 35"-40° C.
Retinoyl ?uoride has the following structure:
Retinoyl ?uoride can be mixed with commercially available glucuronic acid. The reaction is carried out in acetone/water to facilitate the solubility of the water insoluble retinoyl ?uoride and the water-soluble glucu ronic acid. The reaction takes place in slightly alkaline pH and hence sodium bicarbonate is used in the reaction Soc. 77: 3310-3315, 1955 ). The reaction is carried out in the presence of silver carbonate by stirring at room temper ature for 20-24 hours. The resulting product is a mix ture of unconverted retinol and the fully protected glucuronide of retinol. To obtain the free glucuronide, the crude mixture is saponi?ed without separating the other products and then the products are separated by a combination of column chromatography and HPLC.
Compounds to which this invention relate are useful by reason of their valuable pharmacological properties. The biological activities of retinoyl B-glucuronide and retinyl B-glucuronide were determined with respect to retinoic acid and retinyl acetate, respectively. The glucuronides were found to be comparable in activity to that of retinoic acid and retinyl acetate.
Weanling male rats (Holtzman) were made vitamin A de?cient by raising them on a vitamin A de?cient diet for 4-5 weeks. When the rats reached weight-plateau stage, they were divided into ?ve groups: Group I re ceived 2.5 pg of all-trans retinoic acid/rat twice daily. Group II received 2.5 pg of all-trans retinoyl B glucuronide/rat twice daily. Group III received 4.6 pg of all-trans retinyl acetate/rat twice daily. Group IV received 70 pg of all-trans retinyl B-glucuronide/rat/ week by intraparetoneal injection. Rats of Group V did not receive any supplement and lost weight at the end of the bioassay period. Rats in the other four groups grew almost at the same rate (Table 1) . Three grams of retinoic acid was dissolved in 100 ml The results are, of course, speci?ed merely for the purposes of illustration and, accordingly, are not to be construed as either delimiting or exclusionary. Appro priate dosages in any given instance, of course, depend upon the nature and severity of the condition treated, the route of administration, and the species of mammal involved including its size and any individual idiosyn cracies which obtain.
For therapeutic purposes, the compounds of this invention are ordinarily combined with one or more adjuvants appropriate to the indicated route of adminis tration. If per os, they may be admixed with lactose, sucrose, starch powder, cellulose esters of alkanoic acids, cellulose alkyl ethers, talc, steric acid, magnesium 55 65
Synthesis of retinoyl B-glucuronide
Retinoyl ?uoride (2.4 g) was dissolved in 300 ml of acetone. D-Glucuronic acid (6 g) dissolved in 75 ml of water and sodium bicarbonate (6 g) dissolved in 75 ml of water were added to the retinoyl ?uoride solution. The mixture was stirred at room temp. for 12-16 hours.
More water (100-150 ml) was added and the stirring was continued for 8-12 hours more until most of the retinoyl ?uoride had reacted. The solution was diluted with water, acidi?ed with 1N HCl, and the product was extracted with n-butanol. The extract was washed with water, dried over anhydrous sodium sulfate and then evaporated to dryness in a rotary evaporator. The resi-_ due was dissolved in 2-3 ml of diethyl ether and trans ferred to a silica gel (for dry column chromatography, wet packed with hexane) column. The column was developed with hexane containing diethyl ether (5-50%) to remove retinoic acid and other products.
The major yellow band containing retinoyl glucuronide was next eluted with a mixture of CH2Cl2/CH3OH
(1:1). The solvent was evaporated to-dryness to give solid retinoyl glucuronide (2.1 g, 60%) .
An analytically pure sample of retinoyl B-glucuro nide was obtained by HPLC of the above preparation on a Whatman ODS-3 column (M9, 50 cm) using me thanol/water (7:3) containing 10 mM ammonium ace tate at a ?ow rate of 3 ml/min. Retinoyl ,B-glucuronide (tR=48.7 min) separated from traces of isomers or anomers (tR=46.4 min). ) and silver carbonate (1.5 g).
The mixture was stirred in the dark at room tempera ture for 4-6 hours. Diethyl ether was added and the silver carbonate was ?ltered off. The ?ltrate was evapo rated to dryness. The residual oil was dissolved in 50 ml of methanol. To this was added 1.5 g of sodium methyl ate and the mixture was re?uxed at 50° C. for 10-15 min. The solution was cooled, diluted with water, acidi tied with acetic acid, and the product was extracted with n-butanol. The extract was washed with water, dried over sodium sulfate and evaporated to dryness in a rotary evaporator. The residual oil was dissolved in 2-3 ml of diethyl ether and transferred into a silica gel column (silica gel for dry column chromatography was wet packed with hexane). The column was developed with hexane containing 5-50% diethyl ether to remove 
